SYNARC ADDS LIFE SCIENCES INDUSTRY VETERAN GREGORY RICHARD TO LEAD SALES AND MARKETING

SAN FRANCISCO, Calif. – November 01, 2006 – Synarc, Inc., a global leader of clinical trial services offering centralized imaging, study participant recruitment and biochemical marker services to the pharmaceutical, biotechnology and medical device industries, has hired Gregory Richard, former President of Accumin Diagnostics, Inc., as Senior Vice President of Sales and Marketing.  Richard will be responsible for leading Synarc’s global commercial sales and marketing strategy.

Prior to Accumin, Richard held the title of Vice President, Managed Care and Clinical Trials at Quest Diagnostics, Inc., where he was responsible for leading the team that helped manage pharmaceutical and biotechnology companies’ research and development projects.

“Greg has in depth experience in clinical trials and a track record of successfully launching innovative diagnostic and therapeutic products,” said Gary Velasquez, President and Chief Executive Officer of Synarc. “His role is pivotal in positioning Synarc as a true global player, serving the needs of pharmaceutical, biotechnology and medical device companies worldwide.”

“Synarc has a strong foundation based on scientific excellence and customer service in the life sciences arena. I look forward to the opportunity to help Synarc grow and become the industry’s valued partner in advancing our customers’ research and development outcomes,” said Richard.

Richard holds a Bachelor of Arts degree from Westminster College in Missouri and is a member of the College’s Board of Trustees. He serves on the School of Allied Health Advisory Board for the University of Connecticut and is a frequent lecturer at industry conferences. Richard is also a Six Sigma Green Belt and Professional in the Academy for Healthcare Management.

About Synarc

Synarc’s advanced capabilities enable life science industry clients to accelerate clinical trials and decrease the time, uncertainty and cost of product development.  Its clients include many of the world’s top biotechnology, pharmaceutical and medical device companies. The company currently manages more than 200 clinical trials, involving more than 60,000 study participants at sites worldwide.  In 2006, Synarc acquired Denmark-based CCBR, with expertise in study participant recruitment, data management for clinical trials, and scientific publication of clinical trial results.  Synarc has over 600 employees in the U.S., Europe and Asia and operates clinical trials worldwide. For more information on Synarc, Inc. go to www.synarc.com.

#  #  #

Media Contact:
David Yeary
Synarc, Inc.
415-817-7752                                   
david.yeary@synarc.com